Smartkem to Consider Strategic Alternatives
Smartkem (NASDAQ:SMTK), a company developing innovative transistor technology, has announced that its Board of Directors has authorized management to explore strategic alternatives to enhance stockholder value. The company will evaluate potential strategic transactions, though no specific timetable has been established.
While conducting this strategic review, Smartkem emphasizes that it will continue its normal business operations and remain focused on executing its operational plan to advance the commercialization of its patented technology. The company notes that there is no guarantee that this review will result in any transaction or increase in stockholder value.
Smartkem (NASDAQ:SMTK), azienda che sviluppa una tecnologia innovativa per transistor, ha comunicato che il suo Consiglio di Amministrazione ha autorizzato il management a esaminare opzioni strategiche volte a incrementare il valore per gli azionisti. Verranno valutate possibili operazioni strategiche, senza però un programma temporale definito.
Durante questa revisione strategica, Smartkem sottolinea che continuerà le normali attività operative e manterrà l'impegno nell'esecuzione del piano operativo per favorire la commercializzazione della sua tecnologia brevettata. La società precisa che non vi è alcuna garanzia che la revisione conduca a una transazione o a un aumento del valore per gli azionisti.
Smartkem (NASDAQ:SMTK), una empresa que desarrolla tecnología de transistores innovadora, ha anunciado que su Junta Directiva ha autorizado a la dirección a explorar alternativas estratégicas para aumentar el valor para los accionistas. Se evaluarán posibles operaciones estratégicas, aunque no se ha establecido un calendario específico.
Mientras lleva a cabo esta revisión estratégica, Smartkem enfatiza que continuará con sus operaciones normales y seguirá centrada en ejecutar su plan operativo para avanzar en la comercialización de su tecnología patentada. La compañía aclara que no hay garantía de que la revisión resulte en alguna transacción o en un incremento del valor para los accionistas.
Smartkem (NASDAQ:SMTK), 혁신적인 트랜지스터 기술을 개발하는 회사는 이사회의 결정으로 경영진에게 주주가치 제고를 위한 전략적 대안 검토를 지시했다고 발표했습니다. 회사는 잠재적 전략적 거래를 검토할 예정이나 구체적인 일정은 정해지지 않았습니다.
Smartkem은 이 전략 검토를 진행하는 동안 정상적인 영업 활동을 계속하고, 특허 기술의 상용화를 추진하기 위한 운영 계획 실행에 집중할 것이라고 강조했습니다. 또한 이번 검토가 거래 성사나 주주가치 상승으로 이어진다는 보장은 없다고 밝혔습니다.
Smartkem (NASDAQ:SMTK), une société développant une technologie innovante de transistors, a annoncé que son conseil d'administration a autorisé la direction à examiner des alternatives stratégiques afin d'accroître la valeur pour les actionnaires. La société évaluera d'éventuelles transactions stratégiques, sans calendrier précis pour l'instant.
Pendant cette revue stratégique, Smartkem souligne qu'elle poursuivra ses activités normales et restera concentrée sur l'exécution de son plan opérationnel pour faire avancer la commercialisation de sa technologie brevetée. La société précise qu'il n'y a aucune garantie que cette revue aboutisse à une transaction ou accroisse la valeur pour les actionnaires.
Smartkem (NASDAQ:SMTK), ein Unternehmen, das innovative Transistor-Technologie entwickelt, gab bekannt, dass sein Vorstand das Management ermächtigt hat, strategische Alternativen zur Steigerung des Aktionärswerts zu prüfen. Mögliche strategische Transaktionen werden bewertet, ein konkreter Zeitplan wurde jedoch nicht festgelegt.
Während dieser strategischen Überprüfung betont Smartkem, dass das Tagesgeschäft wie gewohnt fortgeführt wird und man sich weiterhin auf die Umsetzung des Betriebsplans zur Förderung der Kommerzialisierung der patentierten Technologie konzentriert. Es bestehe keine Garantie, dass die Überprüfung zu einer Transaktion oder einer Wertsteigerung für die Aktionäre führt.
- Company actively seeking ways to maximize shareholder value through strategic alternatives
- Business operations continue normally during strategic review
- Company maintains focus on commercialization of patented technology
- No guarantee of successful transaction or increased stockholder value
- Strategic review suggests possible challenges in current business model
- Timing of potential transaction remains uncertain
The review will include consideration of transactions intended to increase stockholder value. No timetable has been set for a strategic transaction and there is no assurance that any strategic transaction will result or result in an increase in stockholder value. The Company reserves the right to terminate its review at any time and may determine not to pursue a strategic transaction.
Smartkem intends to continue operating its business in the ordinary course during this process.
While this review is underway, Smartkem remains focused on executing its operational plan to unlock the long-term potential and accelerate towards commercialization of its unique and patented technology.
About Smartkem
Smartkem is seeking to change the world of electronics with a new class of transistors developed using its proprietary advanced semiconductor materials. Our TRUFLEX® semiconductor polymers enable low temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost, high-performance displays. Our semiconductor platform can be used in a range of display technologies including MicroLED, LCD and AMOLED, as well as in applications in advanced computer and AI chip packaging, sensors, and logic.
Smartkem designs and develops its materials at its research and development facility in
The company has an extensive IP portfolio including 140 granted patents across 17 patent families, 14 pending patents and 40 codified trade secrets.
For more information, visit our website or follow us on LinkedIn.
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on Smartkem, Inc.'s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expect," "intend," "plan," "project," "believe," "estimate," and other similar or elated expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. Such forward-looking statements include statements regarding the pursuit of strategic alternatives and the type, timing and consideration to be received by Smartkem or its stockholders in any strategic transaction that may occur. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control, including the ability of Smartkem to locate and consummate a strategic transaction on acceptable terms, if at all, and the timing of any such transaction that may occur or whether any such transaction that is consummated will result in an increase in stockholder value. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
Contacts:
Selena Kirkwood
Head of Communications for Smartkem
T : +44 (0) 7971 460 364
s.kirkwood@smartkem.com
Logo - https://mma.prnewswire.com/media/2749211/5480704/Smartkem_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/smartkem-to-consider-strategic-alternatives-302540403.html
SOURCE SmartKem, Inc.
FAQ
What strategic alternatives is Smartkem (SMTK) considering in August 2025?
Why did Smartkem (SMTK) announce a strategic review in August 2025?
Will Smartkem (SMTK) continue normal operations during the strategic review?
Is there a timeline for Smartkem's (SMTK) strategic alternatives review?
What is the guaranteed outcome of Smartkem's (SMTK) strategic review?
